LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

3.69 -2.38

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.6

Max

3.7800000000000002

Belangrijke statistieken
By Trading Economics
Inkomsten	-3.3M -13M
Verkoop	-1.4M 17M
EPS	-0.712
Winstmarge	-77.289
Werknemers	260
EBITDA	4M -8.1M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+121.11% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-3.4M 118M
Vorige openingsprijs	6.07
Vorige sluitingsprijs	3.69

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 nov 2025, 21:54 UTC

Acquisities, Fusies, Overnames

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24 nov 2025, 18:26 UTC

Belangrijke Marktbewegers

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24 nov 2025, 23:49 UTC

Marktinformatie

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24 nov 2025, 23:08 UTC

Marktinformatie

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24 nov 2025, 23:08 UTC

Marktinformatie

Global Equities Roundup: Market Talk

24 nov 2025, 22:56 UTC

Marktinformatie

Winsten

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24 nov 2025, 22:47 UTC

Marktinformatie

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24 nov 2025, 22:36 UTC

Marktinformatie

Winsten

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24 nov 2025, 22:32 UTC

Winsten

Webco Industries 1Q EPS $6.79 >WEBC

24 nov 2025, 22:07 UTC

Winsten

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24 nov 2025, 22:07 UTC

Winsten

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24 nov 2025, 22:06 UTC

Winsten

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 nov 2025, 22:06 UTC

Winsten

Couche-Tard 2Q Rev $17.9B >ATD.T

24 nov 2025, 22:06 UTC

Winsten

Couche-Tard 2Q EPS 79c >ATD.T

24 nov 2025, 22:05 UTC

Winsten

Couche-Tard 2Q Rev $17.9B >ATD.T

24 nov 2025, 22:05 UTC

Winsten

Couche-Tard 2Q Net $740.6M >ATD.T

24 nov 2025, 22:05 UTC

Winsten

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 nov 2025, 22:05 UTC

Winsten

Couche-Tard 2Q EPS 79c >ATD.T

24 nov 2025, 21:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

24 nov 2025, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

24 nov 2025, 21:44 UTC

Marktinformatie

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24 nov 2025, 21:39 UTC

Acquisities, Fusies, Overnames

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24 nov 2025, 20:42 UTC

Marktinformatie

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24 nov 2025, 20:41 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Lower -- Market Talk

24 nov 2025, 19:56 UTC

Acquisities, Fusies, Overnames

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24 nov 2025, 18:26 UTC

Marktinformatie

Crude Futures Move Higher in Choppy Trade -- Market Talk

24 nov 2025, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

24 nov 2025, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

24 nov 2025, 17:09 UTC

Marktinformatie

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24 nov 2025, 16:52 UTC

Acquisities, Fusies, Overnames

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

121.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8.38 USD 121.11%

Hoogste 14 USD

Laagste 3 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.